-+ 0.00%
-+ 0.00%
-+ 0.00%

Spruce Biosciences to present long-term tralesinidase alfa data in Sanfilippo syndrome Type B at International MPS Symposium

PUBT·05/28/2026 20:09:36
Listen to the news
Spruce Biosciences to present long-term tralesinidase alfa data in Sanfilippo syndrome Type B at International MPS Symposium
  • Spruce Biosciences flagged long-term data for tralesinidase alfa in Sanfilippo syndrome type B for presentation on June 6, 2026.
  • Results will be presented in Florence at the 18th International MPS & Related Lysosomal Diseases Symposium.
  • Study readout points to sustained disease-biomarker reduction with stabilization of cognition and brain gray matter volume over extended treatment.
  • Update keeps the program positioned as a potential late-stage therapy option in a rare neurologic disorder with limited treatment choices.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spruce Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605281605BIZWIRE_USPR_____20260528_BW995547) on May 28, 2026, and is solely responsible for the information contained therein.